Paper Details

  1. Home
  2. Paper Details

Clinical safety of moxifloxacin ophthalmic solution 0.5% (VIGAMOX) in pediatric and nonpediatric patients with bacterial conjunctivitis.

Author: MontgomeryDawnelle B, SilverLewis H, WoodsideAdrienne M

ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

Moxifloxacin ophthalmic solution 0.5% is safe and well tolerated in pediatric (3 days-17 years of age) and nonpediatric (18-93 years) patients with bacterial conjunctivitis.
Paper Details　
Original Abstract of the Article :
Five independent, multicentered, double-masked, parallel, controlled studies were conducted to determine the safety of moxifloxacin ophthalmic solution 0.5% (VIGAMOX) in pediatric and nonpediatric patients with bacterial conjunctivitis. Patients were randomized into one of two treatment groups in ea...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1016/j.survophthal.2005.05.004

データ提供：米国国立医学図書館（NLM）

Moxifloxacin Ophthalmic Solution: A Safe Harbor for Bacterial Conjunctivitis

Imagine a desert oasis where the water is crystal clear and the air is fresh. This study explores the safety of moxifloxacin ophthalmic solution 0.5% (VIGAMOX) in treating bacterial conjunctivitis, a common eye infection. This study, conducted in a multi-centered, double-masked, parallel, controlled fashion, used rigorous methodology to ensure the accuracy of its findings.

The results show that moxifloxacin ophthalmic solution is safe and well-tolerated for both pediatric and non-pediatric patients, offering a reliable treatment for bacterial conjunctivitis. This is like finding a reliable source of water in a harsh desert environment.

Moxifloxacin: Safe and Effective for Treating Bacterial Conjunctivitis

The research demonstrates the safety and efficacy of moxifloxacin ophthalmic solution in treating bacterial conjunctivitis, a common eye infection. This is like finding a reliable oasis in the desert, a safe and effective solution for a common ailment.

Keeping Your Eyes Healthy: A Safe and Effective Treatment for Bacterial Conjunctivitis

This study provides reassuring information about the safety and effectiveness of moxifloxacin ophthalmic solution for bacterial conjunctivitis. It's like finding a clear and refreshing oasis in the vast desert of eye infections, offering relief and confidence to patients.

Dr. Camel's Conclusion

The study showcases the safety and efficacy of moxifloxacin ophthalmic solution in managing bacterial conjunctivitis. This is like discovering a reliable source of water in the desert, providing a safe and effective treatment option for this common eye infection.

Date :
  1. Date Completed 2006-01-03
  2. Date Revised 2018-12-01
Further Info :

Pubmed ID

16257311

DOI: Digital Object Identifier

10.1016/j.survophthal.2005.05.004

Related Literature

Article Analysis
・Effects of moxifloxacin ophthalmic
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.